CAPTRUST Financial Advisors’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25
| Closed | – | – | 2637 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 4980 |
|
|
2022
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 4967 |
|
|
2021
Q4 | $0 | Sell |
25
-1,000
| -98% | – | ﹤0.01% | 4805 |
|
|
2021
Q3 | $10K | Hold |
1,025
| – | – | ﹤0.01% | 3597 |
|
|
2021
Q2 | $9K | Buy |
1,025
+25
| +3% | +$220 | ﹤0.01% | 3589 |
|
|
2021
Q1 | $11K | Buy |
+1,000
| New | +$11K | ﹤0.01% | 3380 |
|